Biomedical Engineering Reference
In-Depth Information
[13] Wang YJ , Pearlman R. Stability and characterization of protein and peptide drugs: case
histories. New York, NY : Plenum Press ; 1993 .
[14] Wall DA . Pulmonary absorption of peptides and proteins . Drug Delivery 1995 ; 2 : 1 - 20 .
[15] Gupta PK , Hickey AJ . Contemporary approaches in aerosolized drug delivery to the
lung . J Control Release 1991 ; 17 : 129 - 48 .
[16] Adjei A , Gupta PK . Pulmonary delivery of therapeutic peptides and proteins . J Control
Release 1994 ; 29 : 361 - 73 .
[17] Crooks P. Lung peptidases and their activities. Paper presented at Respiratory Drug
Delivery II, Keystone, Colorado, March 26- 30; 1990.
[18] Enna SJ , Schanker LS . Phenol red absorption from the rat lung: evidence of carrier trans-
port . Life Sci 1973 ; 12 : 231 - 9 .
[19] Schanker LS , Hemberger JA . Relation between molecular weight and pulmonary absorp-
tion rate of lipid-insoluble compounds in neonatal and adult rats . Biochem Pharmacol
1983 ; 32 : 2599 - 601 .
[20] Effros RM , Mason GR . Measurements of pulmonary epithelial permeability
in vivo
. A m
Rev Respir Dis 1983 ; 127 : S59 - 65 .
[21] Hayem A , Scharfman A , Laine A , Lafitte JJ , Sablonniere B . Proteases and antiproteases
in bronchoalveolar lavage . Bull Eur Physiopathol Respir 1980 ; 16 : 247 - 58 .
[22] Niven RW , Byron PR . Solute absorption from the airways of the isolated rat lung II.
Effects of surfactants on absorption of fluorescein . Pharm Res 1990 ; 7 : 813 .
[23] Niven RW , Rypacek F , Byron PR . Solute absorption from the airways of the isolated
rat lung III. Absorption of several peptidase-resistant, synthetic polypeptides: poly-
(2 - hydroxyethyl) - aspartamides . Pharm Res 1990 ; 7 : 990 - 4 .
[24] Niemeier RW , Bingham E . An isolated perfused lung preparation for metabolic studies .
Life Sci 1972 ; 11 : 807 - 20 .
[25] Brazzell RK , Smith RB , Kostenbauder HB . Isolated perfused rabbit lung as a model for
intravascular and intrabronchiol administration of bronchodilator drugs. I. Isoproterenol .
J Pharm Sci 1982 ; 71 : 1268 - 74 .
[26] Morimoto K , Yamahara H , Lee VHL , Kim K . Dipeptide transport across rat alveolar epi-
thelial cell monolayers . Pharmacol Res 1993 ; 10 : 1668 - 74 .
[27] Morimoto K , Yamahara H , Lee VHL , Kim K . Effects of protease inhibitors on vasopressin
transport across rat alveolar epithelial cell monolayers . Pharmacol Res 1994 ; 11 : 1617 - 22 .
[28] Colthorpe P , Farr SJ , Taylor G , Smith IJ , Wxyaxtt D . The pharmacokinetics of pulmo-
nary-delivered insulin: a comparison of intratracheal and aerosol administration to the
rabbit . Pharm Res 1992 ; 6 : 764 - 8 .
[29] Colthorpe P , Farr SJ , Smith IJ , Wyatt D , Taylor G . The influence of regional deposition
on the pharmacokinetics of pulmonary-delivered human growth hormone in rabbits .
Pharm Res 1995 ; 12 : 356 - 9 .
[30] Agu RU , Ugwoke MI , Armand M , Kinget R , Verbeke N . The lung as a route for systemic
delivery of therapeutic proteins and peptides . Respir Res 2001 ; 2 : 198 - 209 .
[31] Michels MI , Smith RE , Heimlich EM . Adrenal suppression and intranasally applied
steroids . Ann Allergy 1967 ; 25 : 569 - 74 .
[32] Kimmerle R , Rolla AR . Iatrogenic Cushing 's syndrome due to dexamethasone nasal
drops . Am J Med 1985 ; 79 : 535 - 7 .
[33] Illum L . Nasal drug delivery: new developments and strategies . Drug Discovery Today
2002 ; 7 : 1184 - 9 .
[34] Hussain AA . Intranasal drug delivery . Adv Drug Delivery Rev 1998 ; 29 : 39 - 49 .
[35] Vyas TK , Tiwari SB , Amiji MM . Formulation and physiological factors influencing CNS
delivery upon intranasal administration . Crit Rev Ther Drug Carrier Syst 2006 ; 23 : 319 - 47 .
Search WWH ::
Custom Search